ADHD and diabetes drugs to be tested in pioneering Alzheimer’s study
The Independent
A pioneering clinical trial called Ad-Smart is testing ADHD and diabetes drugs for Alzheimer’s, aiming to significantly speed up drug evaluation. The study, led by the UK Dementia Research Institute, uses an innovative design to assess multiple treatments simultaneously, potentially halving the time required for traditional trials. The initiative, supported by the UK government and involving over 20 NHS sites, seeks to identify effective therapies that address various mechanisms of Alzheimer’s disease.
All articles from 22 October 2026. Summaries are AI-generated and may contain errors; the linked article is the authority.